Bo-lai Chen

Guangzhou University of Chinese Medicine

Papers

1

Total Citations

28

H-Index

1

About

Bo-lai Chen is a rising figure in the field of orthopedic surgery, with a focused expertise in robotic-assisted spine surgery and clinical evidence synthesis. His major contribution lies in rigorously evaluating the real-world efficacy of surgical robots, moving beyond technical descriptions to quantify patient outcomes. His landmark 2023 systematic review, which analyzed 20 randomized controlled trials, is the most comprehensive meta-analysis in this niche to date, demonstrating that robotic systems can significantly reduce complication rates and improve screw placement accuracy compared to freehand techniques. With 28 citations already, this work has become a cornerstone reference for surgeons and hospitals considering robotic adoption. Chen’s research is notable for its methodological rigor—he conducted a multi-database search spanning over three decades (1990–2022) and employed strict inclusion criteria, setting a new standard for evidence-based assessment in spine surgery. By bridging the gap between cutting-edge technology and clinical practice, Chen is helping to define the safety and effectiveness benchmarks that will guide the next generation of minimally invasive spinal procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Clinical efficacy of robotic spine surgery: an updated systematic review of 20 randomized controlled trials
28 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Guangzhou University of Chinese Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago